Sun Pharma Finalizes Acquisition of Checkpoint Therapeutics Enhancing Cancer Treatment Options Sun Pharmaceutical Industries has successfully acquired Checkpoint Therapeutics, gaining access to UNLOXCYT™, an FDA-approved treatment for skin cancer, marking a significant step forward in oncology.

Sun Pharma Finalizes Acquisition of Checkpoint Therapeutics Enhancing Cancer Treatment Options #India #Mumbai #UNLOXCYT #Checkpoint_Therapeutics #Sun_Pharmaceutical